Greenlight Capital
VC Fund
New York, United States
Greenlight Capital is a VC fund in New York focused on Software and Biotechnology. Green Light Capital is a privately owned hedge fund sponsor. The firm invests in the public equity and fixed income markets of the United States. It primarily invests in value stocks of companies. The firm employs a fundamental analysis with a market neutral strategy to make its investmens. Green Light Capital was founded in 1996 and is based inthe New York, New York.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries Greenlight Capital invests in
SoftwareBiotechnologyEnterprise SoftwareInformation TechnologyWeb3
Stages Greenlight Capital invests in
Post-IPO EquitySeedSeries ASeries BSeries C
Countries Greenlight Capital invests in
United StatesGermany
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Einhorn
|
|||
|
Steven Rosen
|
|||
3 more contacts available
Investment Focus
Industry
- Software 3 (33%)
- Biotechnology 3 (33%)
- Enterprise Software 2 (22%)
- Information Technology 2 (22%)
- Web3 1 (11%)
Stage
- Post-IPO Equity 4 (44%)
- Seed 1 (11%)
- Series A 1 (11%)
- Series B 1 (11%)
- Series C 1 (11%)
Country
- United States 8 (89%)
- Germany 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Einhorn
President
|
President | Total investments: 1 | Find email | |
|
Steven Rosen
Chief Compliance Officer
|
Chief Compliance Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Coya Therapeutics
|
Coya Therapeutics is a clinical-stage biotechnology company developing first-in-class and best-in-class approaches utilizing adoptive regulatory T cells (Tregs) to target disease. The company’s proprietary CTreg (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf’ approach to Treg cell therapy allowing forserial infusions. Through our patented TAI (Tregs Against Inflammation) and EAITM (Exosomes Against Inflammation) platforms, Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson’s, Alzheimer’s, FTD and autoimmune diseases. | $11.1M / Post-IPO Equity / Jan 30, 2026 | |
Hoodie Analytics
|
Hoodie Analytics was founded on the belief that cannabis businesses need deeper, operational insights to better compete. Our team has decades of experience in cannabis as well as e-commerce intelligence & market measurement in markets like CPG & FMCG.With Hoodie Analytics, you get an indispensable partner tracking the movements of themarket. You get access to the best people, processes, and data which deliver an unfair advantage over the the competition. You can focus on running your business. We’ll deliver the insights needed to outgrow the pack. | $5M / Series A / Jun 27, 2024 | |
X (formerly Twitter)
|
X, formerly Twitter, is a global social networking platform that allows its users to send and read 280-character messages. It enables registered users to read and post their tweets through the web, short message service (SMS), and mobile applications. As a global real-time communications platform, X has more than 400 million monthly visitors and255 million monthly active users around the world. X’s active group of registered members includes World leaders, major athletes, star performers, news organizations, and entertainment outlets. It is currently available in more than 35 languages. X was launched in 2006 by Jack Dorsey, Evan Williams, Biz Stone, and Noah Glass. X is headquartered in San Francisco, California, USA, with local offices in Atlanta, Austin, Boston, Boulder, Chicago, Detroit, Los Angeles, New York, Sunnyvale, and Washington. X's international offices are located in Amsterdam, Berlin, Dublin, London, Madrid, Paris, Rio de Janeiro, Sao Paulo, Singapore, Sydney, Seoul, Tokyo, Toronto, and Vancouver. | Post-IPO Equity / Aug 01, 2022 | |
Atlas Air Worldwide Holdings
|
Atlas Air Worldwide Holdings, Inc. (AAWW) is a holding company with a principal operating subsidiary, Atlas Air, Inc. (Atlas). AAWW is a global provider of outsourced aircraft and aviation operating services. AAWW operates its service offerings in four segments: ACMI, AMC Charter, Commercial Charter and Dry Leasing. It manages and operates a fleetof 747 freighters. AAWW customers include airlines, express delivery providers, freight forwarders, the United States military and charter brokers. It provides global services with operations in Africa, Asia, Australia, Europe, the Middle East, North America and South America. During the year ended December 31, 2011, The Boeing Company (Boeing) delivered three of the 747-8F aircraft to the Company. AAWW also holds rights to purchase an additional 13 747-8F aircraft. In March 2013, Atlas Air Worldwide Holdings Inc's Titan Aviation acquired Boeing 777 Freighter. | Post-IPO Equity / Aug 04, 2020 | |
The Better Meat Co.
|
We harness the power of fermentation to make versatile mycoprotein ingredients for food companies to use as the basis of their blended and fully animal-free meats.We’re laser-focused on solving the meat sustainability crisis our planet faces. By harnessing the power of fermentation, we’re working to enable our species to enjoy all the meat wecrave, but with a tiny sliver of the footprint we currently have on the planet and animals. In short, we aspire to revolutionize the meat industry by creating a new and better way to make meat. It will be delicious; it will be satisfying; and it will be affordable. And it will create a cleaner, greener planet for all of us to enjoy. | $8.1M / Seed / Jul 29, 2020 | |
Software AG
|
Software AG provides business process management, data management, and consulting services worldwide.It operates in three segments: business process excellence, enterprise transaction systems, and consulting. The BPE segment offers software products and services for integrated business process management solutions for organizations in variousindustries. This segment offers ARIS, a technological platform that enables companies to plan, visualize, and evaluate processes, applications, technologies, data, and organizational structures; Alfabet technology platforms for planning and optimizing IT infrastructures; and webMethods, which bridges a service-oriented architecture with process automation/optimization and real-time monitoring and control of applications.It also provides Apama, a platform for real time development of event-driven applications for investment banks, funds, and other institutional traders; Terracotta, which manages data using in-memory technology to search and retrieve results in microseconds; Process Live, a process optimization application; Portfolios Live, a cloud base service for IT portfolio management; and Agile AppsLive for non IT-business units.The ETS segment provides database solutions for mainframes, and development and modernization of mainframe-based IT systems. This segment offers Adabas, database management system; and Natural, a development environment that allows users to create new programs and modify existing ones. The consulting segment provides SAP consulting services for process consulting and German-speaking countries. | Post-IPO Equity / Jan 21, 2020 | |
IEX Group
|
IEX is an equity trading venue seeded by a consortium of buy-side investors, including mutual funds, hedge funds, and family offices. IEX focuses on investor protection and performance by creating a market that aims to maximize shares traded at the best available price, decrease information leakage, eliminate informational disadvantages andpersistent inefficiencies, and promote an opportunity for natural interest to interact without unnecessary intermediation. IEX is dedicated to offering fair access to a balanced marketplace, and delivering a defined and objective experience in support of just and equitable principles of trade.IEX operates a fair-access platform for any qualified broker dealer, and was built on the principle of investor protection, delivered through its proprietary anti-colocation architecture and simplified pricing and rule set. IEX was featured in the best-selling book, Flash Boys, written by Michael Lewis. | $24.4M / Series B / Mar 01, 2013 | |
Ception Therapeutics
|
Ception Therapeutics is a biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need. Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need. | $14.7M / Series C / May 31, 2007 | |
WebGen Systems
|
WebGen Systems provides advanced software for energy conservation and control in commercial buildings. They combine the highest level of industry expertise with a reliable suite of open-protocol software tools called IUE®, which provides real-time command of energy use to generate savings. There system connects all aspects of building energymanagement to automatically measure, monitor, and control energy consumption building by building, system by system, meter by meter, and device by device. In this way, they offer the most effective Enterprise Energy Management solution on the market today. | $9.5M / Jun 01, 2006 |
Co-Investors
Third Point Ventures
2 deals together
Belfer Management LLC
1 deal together
Bossa Invest
1 deal together
Brandes Investment Partners
1 deal together
Capital Group
1 deal together
Dr. Reddy’s Laboratories
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Enterprise Software Investors
13,836 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
Software VC Funds
31,919 investors
FAQ
What does Greenlight Capital invest in?
Greenlight Capital invests primarily in Software, Biotechnology and Enterprise Software startups, most often at Post-IPO Equity and Seed stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Greenlight Capital?
Public channels for Greenlight Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Greenlight Capital?
The team at Greenlight Capital includes David Einhorn (President) and Steven Rosen (Chief Compliance Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
